Contact: Katie Glenn, firstname.lastname@example.org, 202-375-6472
WASHINGTON (Apr 26, 2017) -
The number of implantable cardioverter defibrillators (ICDs) that use two coils to shock the heart has decreased in the last five years but are still more common than single coil models, according to a study published in JACC: Clinical Electrophysiology. There is emerging evidence that dual coil ICDs are not associated with lower mortality or lower rates of failed ICD shocks than single coil models in treating arrhythmias and are more difficult to extract.
An ICD is a small device placed in the chest or abdomen to treat life-threatening arrhythmias. The ICD has a lead—or wire—that connects to the bottom right chamber of the heart. This wire has coils, which deliver shocks to help treat life-threatening arrhythmias that can cause sudden cardiac arrest. The first ICDs had two coils (dual coil).
"The thinking was that the two coils generated more energy and would deliver a more efficient shock," said Sean Pokorney, MD, a cardiologist at Duke University in Durham, North Carolina, and lead author of the study.
Improvements in design have allowed modern ICDs to deliver more energy in more efficient ways than the early ICDs, decreasing the potential benefit from a dual versus a single coil lead.
Some patients with ICDs need to have them removed because of infection or because the leads or wires break or stop working. Dual coil ICD leads are more difficult to remove, which has been a factor in the growing popularity of single coil ICD leads, Pokorney said.
"It's surprising that at the end of 2015, the majority of ICDs were still dual coil," he said.
The new study analyzed data from the National Cardiovascular Data Registry's ICD Registry of 435,772 patients at 1,690 hospitals who underwent ICD lead implantation between April 2010 and December 2015. The researchers found nationally, the use of dual coil leads decreased from 85 percent in early 2010 to 55 percent in 2015. As all leads are either dual coil or single coil, the percentage of single coil leads increased from 15 percent in 2010 to 45 percent in 2015. Hospitals that extracted more ICDs were more likely to use single coil ICDs.
Hospitals that had more ICDs implanted by arrhythmia specialists known as electrophysiologists were also more likely to use single coil models. Electrophysiologists are more likely to be involved in ICD extraction than other cardiologists who implant devices and, therefore, more acutely aware of the challenges that dual coil leads present, Pokorney said.
The researchers divided the hospitals into three groups: low, decreasing or high use of dual coil ICD leads. They found 90 percent of hospitals in the low-use group had ICDs implanted by electrophysiologists, compared with 80 percent in the decreasing use and 46 percent in the high use group. Hospitals in the low or decreasing use groups were also more likely to be sites performing higher volumes of extractions.
Certain types of patients may be at higher risk of arrhythmia complications and might be expected to receive dual coil ICDs in order to receive more effective shocks. These patients include obese patients, African-American patients, those taking the arrhythmia drug amiodarone, patients with end-stage kidney disease on dialysis or those with advanced heart failure. However, the study found providers do not appear to be selecting dual coil ICD leads based on patients’ risk levels.
"The data show that hospital-level factors are driving decision-making around ICDs instead of being more patient-focused," Pokorney said.
The researchers said future studies should examine whether the decreasing trend in use of dual coil ICD lead is associated with improved patient outcomes.
The American College of Cardiology is the professional home for the entire cardiovascular care team. The mission of the College and its more than 52,000 members is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, offers cardiovascular accreditation to hospitals and institutions, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more, visit acc.org.
The Journal of the American College of Cardiology is the most widely read cardiovascular journal in the world and is the top ranked cardiovascular journal for its scientific impact. JACC is the flagship for a family of journals that publish peer-reviewed research on all aspects of cardiovascular disease. JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging and JACC: Heart Failure also rank among the top ten cardiovascular journals for impact. JACC: Clinical Electrophysiology and JACC: Basic to Translational Science are the newest journals in the JACC family. Learn more at JACC.org.